Source comparison
Best Sermorelin Dosage Comparison: Research Protocols and Clinical Data
100–150mcg 4–8ng/mL 60–90 min post-injection Minimal Subtherapeutic for most adult applications. May be appropriate for paediatric or highly GH-sensitive populations 200–300mcg 12–20ng/mL Low Standard therapeutic range. Balances efficacy with minimal desensiti
This comparison does not assign a generated winner or score.
- 100–150mcg
- 4–8ng/mL
- 60–90 min post-injection
- Minimal
- Subtherapeutic for most adult applications. May be appropriate for paediatric or highly GH-sensitive populations
- 200–300mcg
- 12–20ng/mL
- Low
- Standard therapeutic range. Balances efficacy with minimal desensitisation risk when dosed nocturnally
- 400–500mcg
- 18–25ng/mL
- Moderate
- Near-maximal response. Higher doses provide diminishing returns due to receptor saturation
- 600–1000mcg
- 20–28ng/mL
- High
- No proportional benefit over 400–500mcg. Increased cost and desensitisation risk without meaningful GH elevation gain